Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.74 |
| ▸ | MEN1 | O00255 | 8/20 | 0.74 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | ESRRG | P62508 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20299131 | 1.00 | RAB9A (1.00) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL13568982 | 0.92 | RAB9A (0.87) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL30529940 | 0.91 | RAB9A (0.83) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL2830919 | 0.88 | RAB9A (0.81) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL711755 | 0.88 | RAB9A (0.81) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL711754 | 0.88 | RAB9A (0.81) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL12305546 | 0.87 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL13568878 | 0.87 | RAB9A (0.97) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL8253424 | 0.85 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL1129157 | 0.85 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190336610-A1 | GLUCOSE-SENSITIVE PEPTIDE HORMONES | GUBRA APS (DK) | 2019-11-07 | — | — | US | disclosed |
| EP-3558383-A1 | GLUCOSE-SENSITIVE PEPTIDE HORMONES | Gubra ApS (DK) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018115462-A1 | GLUCOSE-SENSITIVE PEPTIDE HORMONES | GUBRA APS (DK) | 2018-06-28 | — | — | WO | disclosed |
| CN-1302290-A | Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions | INST ORCH SINTEZA URAL OTDEL R (RU) | 2001-07-04 | — | — | CN | disclosed |
| EP-1081131-A1 | SELECTIVE ANTI-MYCOBACTERIAL PREPARATIONS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS | Institut Organicheskogo Sinteza Uralskogo Otdeleniya Rossiiskoi Akademii Nauck (RU) | 2001-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190336610-A1 | GLUCOSE-SENSITIVE PEPTIDE HORMONES | IAPP, GCG, VIP | RAB9A 3872/4885NPC1 2223/4885SMN1; SMN2 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.